Pozharitskaya Olga N, Karlina Marina V, Shikov Alexander N, Kosman Vera M, Makarov Valery G, Casals Eudald, Rosenholm Jessica M
Saint Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, 188663, Kuzmolovo P 245, Russia.
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, BioCity (3rd Floor), Tykistökatu 6A, 20520, Turku, Finland.
Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):327-332. doi: 10.1007/s13318-016-0340-7.
Betulin is a triterpene extracted from the cork layer of the outer bark of Betula spp. It has a wide spectrum of pharmacological activities, including being lung protective; however, its bioavailability is low. To increase its bioavailability, betulin was entrapped in a nanosystem (BN). In this study, we investigated the pharmacokinetics and tissue distribution of nanosystem-entrapped betulin after single dose endotracheal administration to rats.
Betulin was nanosystem-entrapped using a solvent exchange technique. The surface morphology and size of the nanosystem were characterized by transmission electron microscopy and dynamic light scattering. The plasma and tissue concentrations of betulin were determined using a validated high-performance liquid chromatography method.
The highest concentration of betulin was found in lungs and liver, and the lowest in the heart. Betulin did not penetrate highly vascularized tissues or tissue with an average degree of vascularization, nor did it cross the blood-brain barrier. Tissue availability in the lungs was 1.3 times higher for BN than for free betulin. Betulin was detected in the bloodstream at 15 min after administration of BN compared with only at 1 h after administration of free betulin. Penetration of betulin in the liver tissue was characterized by a high degree of intensity both for BN and free betulin. Betulin in the heart tissue was detected in much smaller quantities than in the liver.
Entrapment of betulin in nanosystem form shows promise as a novel strategy in the treatment of pulmonary diseases.
桦木醇是从桦木属植物外树皮的软木层中提取的一种三萜类化合物。它具有广泛的药理活性,包括肺保护作用;然而,其生物利用度较低。为提高其生物利用度,将桦木醇包裹于纳米系统中(BN)。在本研究中,我们调查了纳米系统包裹的桦木醇经单次气管内给药至大鼠后的药代动力学及组织分布情况。
采用溶剂交换技术将桦木醇包裹于纳米系统中。通过透射电子显微镜和动态光散射对纳米系统的表面形态和大小进行表征。使用经过验证的高效液相色谱法测定桦木醇的血浆和组织浓度。
桦木醇在肺和肝脏中的浓度最高,在心脏中的浓度最低。桦木醇未渗透至高度血管化组织或具有平均血管化程度的组织,也未穿过血脑屏障。BN在肺中的组织可利用性比游离桦木醇高1.3倍。给予BN后15分钟在血流中检测到桦木醇,而给予游离桦木醇后1小时才检测到。BN和游离桦木醇在肝组织中的桦木醇渗透均表现为高强度。心脏组织中检测到的桦木醇量比肝脏中的少得多。
以纳米系统形式包裹桦木醇显示出作为治疗肺部疾病新策略的前景。